What's the outlook for the Bank of Queensland share price in April?

How are things looking for BOQ shares? Let's see what the experts say…

| More on:
A fortune teller looks into a crystal ball in an office surrounded by business people.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The BOQ share price has been volatile over the last few months
  • Brokers think that its margins are being, or could be, challenged
  • Morgan Stanley thinks BOQ is a buy, but others are less optimistic

The first few months of 2022 have been volatile for the S&P/ASX 200 Index (ASX: XJO). But what is the outlook for the Bank of Queensland Limited (ASX: BOQ) share price?

Recent history has been a strange period for BOQ shares. The past month shows an 11% rise for the challenger bank. However, it's only up by 2% since the start of 2022. Looking further back, the BOQ share price has fallen 13% in the past six months.

At the time of writing, it is down 0.35% in early trade today to $8.44.

What next for the BOQ share price?

It's impossible to know what's going to happen in any given week, month, or even year for an investment. Just look at how COVID-19 turned the world upside down over the past two years.

However, two brokers recently downgraded their ratings on the bank. Ord Minnett downgraded its rating to a hold, and Macquarie downgraded its rating to neutral. The Ord Minnett price target is $8.90, and the Macquarie price target is $9.

Those two brokers suggested that BOQ's net interest margin (NIM) could come under pressure. Competition continues to be strong in the lending space and is expected to remain like that. Macquarie doesn't think the upcoming result will impress the market due to the NIM challenges.

However, one positive note from a broker about BOQ this month came from Morgan Stanley. The broker believes the bank can achieve the 'positive jaws' that it has been aiming for. It has a price target of $10.20 on the business.

BOQ is now a larger business after the acquisition of ME Bank.

The bank recently said that it was revising its accounting policy in relation to costs relating to software-as-a-service arrangements. The change led to a $25 million decrease in retained earnings as of 1 September 2021.

BOQ share price valuation and dividend expectations

Based on Morgan Stanley's numbers, the Bank of Queensland share price is valued at 12x FY22's estimated earnings with a potential FY22 grossed-up dividend yield of 7.8%.

Looking further ahead to FY23, Morgan Stanley's estimate put the BOQ share price at 11x FY23's projected earnings. The FY23 grossed-up dividend yield is expected to be 8.6%.

Interestingly, Macquarie actually thinks BOQ will generate more profit in FY22 than what Morgan Stanley has pencilled in. Macquarie's estimates put the BOQ share price at under 12x FY22's estimated earnings. The projected FY22 grossed-up dividend yield could be 7.6%.

Macquarie has also estimated some numbers for FY23 for the bank. The BOQ share price is valued at 11x FY23's estimated earnings with a possible grossed-up dividend yield of 8.1%.

New chief financial officer

BOQ announced this morning that it has appointed Racheal Kellaway as its new chief financial officer (CFO). She will succeed the current CFO on 1 July 2022.

The bank said this transition period would ensure a smooth handover of responsibilities.

Kellaway has been the deputy CFO for the past three years. BOQ said Kellaway has been instrumental in BOQ delivering sustainable, profitable growth. She will become the first female CFO in the bank's 148-year history.

The bank said the appointment and transition period positions the bank to maintain momentum in executing its transformation plan, strengthening the balance sheet, and managing costs.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Bank Shares

Businessman smiles with arms outstretched after receiving good news.
Bank Shares

CBA and Klarna: What a $1.8 billion IPO windfall could mean for shareholders

The bank's ongoing rise continues to defy the bearish crowd.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Bank Shares

$10,000 invested in Westpac shares 12 months ago is now

Would you be smiling now if you invested in the big four bank a year ago? Let's see.

Read more »

a woman wearing the black and yellow corporate colours of a leading bank gazes out the window in thought as she holds a tablet in her hands.
Bank Shares

These 3 headwinds make CBA shares a sell: expert

This leading expert believes now is a good time to take profit on CBA shares. Let’s find out why.

Read more »

Happy young woman saving money in a piggy bank.
Bank Shares

Are ANZ shares still in the buy zone near 6-month highs

Bank stocks have rallied hard in 2024.

Read more »

Bank building in a financial district.
Bank Shares

Is this the $350 million reason the Big Four bank shares are falling today?

It’s another challenging day for banks.

Read more »

Young professional person providing advise to older couple.
Bank Shares

NAB shares sink on ASIC legal action

The banking giant failed 345 of its most vulnerable customers.

Read more »

Nervous customer in discussions at a bank.
Bank Shares

Is the NAB share price actually expensive?

Should investors be looking at NAB stock as a bargain?

Read more »

CBA share price represented by branch welcome sign
Bank Shares

Own CBA shares? Here's a major milestone you may have missed this week

CBA shares marked a groundbreaking achievement this week.

Read more »